Reply to Wilson <i>et al.</i> : The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution
Crossref DOI link: https://doi.org/10.1164/rccm.202503-0679LE
Published Online: 2025-08-01
Published Print: 2025-08-01
Update policy: https://doi.org/10.1164/crossmarkpolicies
Saukkonen, Jussi
Munsiff, Sonal
Winston, Carla
Duarte, Raquel
Mammen, Manoj https://orcid.org/0000-0003-0343-3234
Version of Record valid from 2026-03-11
Publication History
Published: 2025-08-01
